Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck

R. Allison, Ron; A. Ambrad, Aaron; Arshoun, Youssef; J. Carmel, Richard; Ciuba, D.; Feldman, Elizabeth; E. Finkelstein, Steven; Gandhavadi, Ranjini; E. Heron, Dwight; C. Lane, Steven; Longo, J.M.; J. Meakin, Charles; Papadopoulos, Dimitrios; E. Pruitt, David; M. Steinbrenner, Lynn; Alan Taylor, Michael; M. Wisbeck, William; E. Yuh, Grace; P. Nowotnik, David; T. Sonis, Stephen

doi:10.1002/cncr.28553

Public

Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck

Published in Cancer • Feb 11, 2014

Authors:

Ron R. Allison

Aaron A. Ambrad

Youssef Arshoun

Abstract

BACKGROUND: The objective of this trial was to determine how a mucoadhesive hydrogel (MuGard), a marketed medical device, would fare when tested with the strictness of a conventional multi-institutional, double-blind, randomized, placebo-controlled study format. METHODS: A total of 120 subjects plan...

Subject

Medicine

Mucositis

Adverse effect

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!